https://sls-eu.com/results-of-sakk-06-14-trial-with-vpm1002bc-as-treatment-for-non-muscle-invasive-bladder-cancer-have-been-published-in-european-urology-oncology/2022-07-11T05:02:17+00:00https://sls-eu.com/prime-update-visit-of-the-south-african-clinical-sites/2022-07-11T05:03:59+00:00https://sls-eu.com/prime-update-visit-to-the-east-african-clinical-sites/2022-07-11T04:46:52+00:00https://sls-eu.com/milestone-achieved-50-recruitment-for-a-large-african-trial-against-tuberculosis-in-neonates-completed/2022-07-27T07:27:07+00:00https://sls-eu.com/updates-on-prime/2022-07-11T05:08:20+00:00https://sls-eu.com/vpm1002-is-a-frontrunner-tuberculosis-tb-vaccine-candidate/2022-07-11T05:11:15+00:00https://sls-eu.com/recruitment-has-started-at-all-clinical-centers/2022-07-11T05:13:52+00:00https://sls-eu.com/memo-therapeutics-ag-antibodies-against-sars-cov-2-show-efficacy-against-british-and-south-african-variant/2022-07-11T05:15:44+00:00https://sls-eu.com/covivaxx-a-new-covid-19-vaccine-under-development/2022-07-11T05:17:45+00:00https://sls-eu.com/prime-on-south-african-newspaper/2022-07-11T05:19:43+00:00https://sls-eu.com/milestone-achieved-initiation-of-all-clinical-centers-for-a-large-african-trial-against-tuberculosis-in-neonates-completed/2022-07-27T07:31:36+00:00https://sls-eu.com/update-on-prime-study/2022-07-11T05:22:22+00:00https://sls-eu.com/first-clinical-center-in-south-africa-initiated-for-a-pan-african-phase-iii-trial-against-tuberculosis/2022-07-11T05:23:50+00:00https://sls-eu.com/press-release-on-vpms-covid-19-study-published-in-neue-presse/2022-07-11T05:26:05+00:00https://sls-eu.com/first-vaccinee-enrolled-in-a-large-phase-iii-trial-against-tuberculosis-in-a-pan-african-setting/2022-07-26T15:03:14+00:00https://sls-eu.com/tdap-study-enters-phase-iii/2022-07-27T09:21:48+00:00https://sls-eu.com/30-million-euro-loan-from-the-eib-for-tb/2022-07-27T07:58:46+00:00https://sls-eu.com/hope-for-the-elderly-in-the-corona-pandemic/2022-07-27T11:11:28+00:00https://sls-eu.com/sars-cov-2-study-kicks-off-in-germany/2022-07-27T11:13:58+00:00https://sls-eu.com/immune-boost-against-the-corona-virus/2022-07-11T05:39:28+00:00https://sls-eu.com/first-volunteer-enrolled/2022-07-27T10:43:57+00:00https://sls-eu.com/modified-tb-vaccine-as-a-therapy-for-bladder-cancer/2022-07-27T11:18:34+00:00https://sls-eu.com/prime-avaref-meeting/2022-07-11T05:44:04+00:00https://sls-eu.com/phd-award-for-alexandra-hierweger/2022-07-27T07:37:48+00:00https://sls-eu.com/prime-investigator-meeting/2022-07-11T05:49:27+00:00https://sls-eu.com/press-release-on-the-12th-international-vpm-days-2019/2022-07-27T08:04:50+00:00https://sls-eu.com/prime-consortium-kick-off-meeting/2022-07-11T06:14:58+00:00https://sls-eu.com/press-reviews-on-tuberculosis-vaccine-vpm1002-2/2023-11-29T15:51:33+00:00https://sls-eu.com/milestone-achieved-end-of-recruitment-for-a-large-african-trial-against-tuberculosis-in-neonates-completed/2022-07-11T04:09:57+00:00https://sls-eu.com/tuberculosis-vaccine-candidate-vpm1002-safe-in-hiv-and-non-hiv-exposed-newborns-as-study-shows/2022-08-02T11:37:20+00:00https://sls-eu.com/article-about-vpms-tuberculosis-tb-vaccine-published-in-the-frankfurter-rundschau/2022-08-12T12:28:45+00:00https://sls-eu.com/vpm_days_2022/2022-11-08T13:10:54+00:00https://sls-eu.com/publication/2022-12-01T14:32:10+00:00https://sls-eu.com/press-release/2023-01-12T05:20:47+00:00https://sls-eu.com/vpm-oversees-clinical-trial-and-translational-project-management-positive-phase-i-data-of-client-memo-therapeutics-ag-2/2023-02-03T06:37:24+00:00https://sls-eu.com/vpm-contributes-to-the-successful-licensure-of-the-novel-malaria-vaccine-r21-matrix-mtm-for-first-use-in-ghana/2023-05-10T12:42:36+00:00https://sls-eu.com/vpm-helps-facilitate-fast-track-designation-for-memo-therapeutics-ags-antibkv-first-in-class-treatment-for-bk-virus-infection-in-renal-transplant-recipients/2023-05-11T05:07:59+00:00https://sls-eu.com/stefan-kaufmann-advocates-for-advancements-in-tuberculosis-control/2023-08-31T09:57:31+00:00https://sls-eu.com/who-recommends-r21-matrix-m-vaccine-for-malaria-prevention/2023-10-10T16:01:28+00:00https://sls-eu.com/clinical-trial-results-for-siipl-tdap-are-online/2023-11-01T15:15:06+00:00https://sls-eu.com/recap-sls-europe-at-bioeurope-and-edctp-forum/2023-11-29T15:21:11+00:00https://sls-eu.com/the-prime-trial-gathers-momentum/2023-11-20T16:30:18+00:00https://sls-eu.com/first-day-insights-from-the-prime-annual-meeting/2024-01-05T17:00:36+00:00https://sls-eu.com/wrapping-up-primes-annual-meeting-a-journey-towards-success-2/2024-01-05T11:57:13+00:00https://sls-eu.com/indias-tb-battle-explored-bbc-news-insights-on-vpm1002/2024-01-05T17:04:02+00:00https://sls-eu.com/reflecting-on-a-successful-presence-at-tbvi-symposium-2024-in-les-diablerets/2024-01-31T15:05:20+00:00https://sls-eu.com/sls-europe-partners-with-incate-to-support-efforts-against-antimicrobial-resistance/2024-02-26T12:00:08+00:00https://sls-eu.com/sls-europe-will-be-at-the-amr-conference-2024/2026-02-09T09:34:58+00:00https://sls-eu.com/two-key-appointments-within-our-leadership-team-at-sls-europe/2024-04-19T13:44:54+00:00https://sls-eu.com/bring-your-product-development-to-life/2024-06-07T14:36:49+00:00https://sls-eu.com/the-15th-international-sls-days-2/2024-10-14T07:43:16+00:00https://sls-eu.com/positive-chmp-opinion-for-siiltibcy-2/2025-01-15T09:20:46+00:00https://sls-eu.com/positive-chmp-opinion-for-siiltibcy/2025-02-18T09:11:38+00:00https://sls-eu.com/sls-europe-at-the-tbvi-symposium-in-les-diablerets/2025-01-31T13:40:58+00:00https://sls-eu.com/sls-europe-at-niedersachsischer-life-science-tag-2025/2025-06-11T16:26:58+00:00https://sls-eu.com/reflection-on-the-joint-symposium-2025/2025-09-25T13:56:57+00:00https://sls-eu.com/sls-europe-joins-ausenwirtschaftstag-2025-in-berlin/2025-10-27T11:59:20+00:00https://sls-eu.com/sls-europe-at-the-union-world-conference-on-lung-health-2025/2025-11-20T09:21:54+00:00https://sls-eu.com/sls-europe-to-attend-gesprach-mit-der-chemie-in-hannover/2026-02-11T09:01:52+00:00https://sls-eu.com/vpm1002-phase-3-results-in-tb-prevention/2026-04-13T06:34:10+00:00https://sls-eu.com/transferxmachen/2026-04-20T08:09:23+00:00https://sls-eu.com/sls-europe-attending-isppd-2026-in-copenhagen/2026-05-12T09:21:34+00:00https://sls-eu.com/sls-days-2026/2026-05-13T14:35:45+00:00https://sls-eu.com/we-are-proud-to-see-the-prime-phase-3-trial-of-vpm1002-published-in-the-lancet-infectious-diseases/2026-08-21T12:27:38+00:00